Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q4 2025

Type / Class
Equity / Class A Common Stock, $0.001 par value per share
Symbol
BVS on Nasdaq
Shares outstanding
66,970,133
Price per share
$7.70
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
37,348,309
Total reported value
$277,825,822
% of total 13F portfolios
0%
Share change
+879,290
Value change
+$6,655,097
Number of holders
96
Price from insider filings
$7.70
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 9% +13% $46,565,003 +$5,902,520 6,047,403 +15% Nantahala Capital Management, LLC 31 Dec 2025

As of 31 Dec 2025, 96 institutional investors reported holding 37,348,309 shares of Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS). This represents 56% of the company’s total 66,970,133 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) together control 52% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Essex Woodlands Management, Inc. 19% 13,021,324 0% 30% $96,878,651
Nantahala Capital Management, LLC 9% 6,047,403 +4.1% 2.7% $44,992,678
BlackRock, Inc. 4.7% 3,124,184 +1.8% 0% $23,243,930
VANGUARD GROUP INC 4.5% 2,984,927 +2.1% 0% $22,207,857
ROYCE & ASSOCIATES LP 1.9% 1,251,282 -0.93% 0.09% $9,309,538
GEODE CAPITAL MANAGEMENT, LLC 1.7% 1,120,238 +1.8% 0% $8,337,051
STATE STREET CORP 1.3% 891,024 +1.7% 0% $6,629,219
AMERICAN CENTURY COMPANIES INC 1.3% 847,791 -22% 0% $6,307,565
DIMENSIONAL FUND ADVISORS LP 1.1% 765,208 +2.9% 0% $5,693,196
RENAISSANCE TECHNOLOGIES LLC 0.92% 615,100 -24% 0.01% $4,576,344
KENNEDY CAPITAL MANAGEMENT LLC 0.69% 462,559 +0.21% 0.07% $3,441,439
ESSEX INVESTMENT MANAGEMENT CO LLC 0.58% 387,886 0.44% $2,885,872
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.56% 375,173 -16% 0% $2,791,287
GOLDMAN SACHS GROUP INC 0.55% 369,818 -5.8% 0% $2,751,445
TOCQUEVILLE ASSET MANAGEMENT L.P. 0.49% 330,000 +8.2% 0.04% $2,455,200
BNP PARIBAS FINANCIAL MARKETS 0.49% 325,864 0% 0% $2,424,428
MORGAN STANLEY 0.45% 302,258 +24% 0% $2,248,802
Knights of Columbus Asset Advisors LLC 0.43% 290,285 -3.2% 0.12% $2,159,720
MARSHALL WACE, LLP 0.43% 288,900 +0.45% 0% $2,149,416
Hillsdale Investment Management Inc. 0.4% 269,909 0.06% $2,008,123
JANE STREET GROUP, LLC 0.4% 269,252 -2.1% 0% $2,003,235
Squarepoint Ops LLC 0.29% 191,173 +29% 0% $1,422,327
PANAGORA ASSET MANAGEMENT INC 0.27% 178,064 -45% 0% $1,324,796
Mariner, LLC 0.24% 160,312 -1.4% 0% $1,192,726
Bank of New York Mellon Corp 0.22% 150,102 +14% 0% $1,116,759

Institutional Holders of Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 37,348,309 $277,825,822 +$6,655,097 $7.44 96
2025 Q3 49,169,136 $328,942,973 +$4,728,359 $6.69 133
2025 Q2 48,385,322 $320,311,775 +$5,188,602 $6.62 132
2025 Q1 46,840,874 $428,590,821 +$16,740,551 $9.15 143
2024 Q4 45,507,445 $477,832,216 +$658,698 $10.50 149
2024 Q3 44,941,761 $537,109,536 +$77,623,131 $11.95 137
2024 Q2 38,578,679 $221,831,767 +$26,597,543 $5.75 100
2024 Q1 34,228,194 $177,979,045 +$4,782,770 $5.20 84
2023 Q4 33,292,235 $175,449,385 +$2,510,502 $5.27 80
2023 Q3 32,998,084 $108,893,302 +$3,595,601 $3.30 67
2023 Q2 31,892,411 $92,170,679 +$3,183,214 $2.89 65
2023 Q1 31,258,956 $33,581,111 -$4,749,675 $1.07 71
2022 Q4 31,381,765 $81,902,823 -$22,341,854 $2.61 84
2022 Q3 35,052,070 $245,361,886 +$7,458,042 $7.00 93
2022 Q2 33,976,343 $231,717,964 +$12,640,844 $6.82 93
2022 Q1 31,706,911 $446,993,897 +$7,048,976 $14.10 100
2021 Q4 31,175,535 $451,621,332 +$89,759,637 $14.49 94
2021 Q3 24,847,152 $351,827,300 +$55,491,790 $14.16 66
2021 Q2 20,703,857 $364,387,973 -$15,203,525 $17.60 51
2021 Q1 21,873,216 $334,224,000 +$334,224,000 $15.28 45